Skip to main content
. 2017 Nov 6;17:69. doi: 10.1186/s12902-017-0214-2

Table 2.

Adherence with local guidelines

Diagnosis confirmed clinically and biochemically 100%
Removal of potential culprit drugs 100%
Exclusion of adrenal / thyroid pathology 100%
Documentation of fluid balance status and charts 92%
Documentation of 48 h fluid restriction prior to starting Tolvaptan 96%
Tolvaptan initiation according to Trust policy 96%
Na level monitoring before/after initiation as per recommendations 96%